Welcome to CDC stacks | Epidemiology and clinical features of Lyme disease - 44554 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Epidemiology and clinical features of Lyme disease
Filetype[PDF-6.43 MB]


This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
Epidemiology and clinical features of Lyme disease
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Epidemiological and clinical features of 1,149 persons with Lyme disease identified by laboratory-based surveillance in Connecticut.
    Personal Author:
    Petersen, L. R.; Sweeney, A. H.; Checko, P. J.; Magnarelli, L. A.; Mshar, P. A.; Gunn, R. A.; Hadler, J. L.;
    Published:
    1989 May-Jun
    Source:
    Yale J Biol Med. 62(3):253-262.
    Description:
    Laboratory-based surveillance of Lyme disease in Connecticut during 1984 and 1985 identified 3,098 persons with suspected Lyme disease; 1,149 were defined as cases. Lyme disease incidence in Connecticut towns ranged from none to 1,407 cases per 100,0...
    File Type:
    Filetype[PDF - 1.04 MB]
  2. Recommendations for the use of Lyme disease vaccine; recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Dennis, David T. (David Tappen), 1939-; Hayes, Edward B.; Meltzer, Martin I.; Orloski, Kathleen A.;
    Corporate Author:
    National Center for Infectious Diseases (U.S.), Division of Vector-Borne Infectious Diseases.. Centers for Disease Control and Prevention (U.S.). National Center for Infectious Diseases (U.S.), Office of the Director.. United States, Advisory Committee on Immunization Practices..
    Published:
    June 4, 1999
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 48, no. RR-7
    Description:
    This report provides recommendations for use of a newly developed recombinant outer-surface protein A (rOspA) Lyme disease vaccine (LYMErix, SmithKline Beecham Pharmaceuticals) for persons aged 15-70 years in the United States. The purpose of these r...
    Status:
    retired
    File Type:
    Filetype[PDF - 741.22 KB]
  3. Risk for human tick-borne encephalitis, borrelioses, and double infection in the pre-Ural region of Russia.
    Personal Author:
    Korenberg, E. I.; Gorban, L. Y.; Kovalevskii, Y. V.; Frizen, V. I.; Karavanov, A. S.;
    Published:
    2001 May-Jun
    Source:
    Emerg Infect Dis. 7(3):459-462.
    Description:
    We assessed the risk for human tick-borne encephalitis (TBE), ixodid tick-borne borrelioses, and double infection from 1994 to 1998 in Perm, which has among the highest rates of reported cases in Russia. We studied 3,473 unfed adult Ixodes persulcatu...
    File Type:
    Filetype[PDF - 59.11 KB]
  4. Lyme disease surveillance in England and Wales, 1986 1998.
    Personal Author:
    Smith, R.; O'Connell, S.; Palmer, S.;
    Published:
    2000 Jul-Aug
    Source:
    Emerg Infect Dis. 6(4):404-407.
    Description:
    Improved surveillance indicates that Lyme borreliosis, an emerging zoonosis in the United Kingdom, has increased from 0.06/100,000 during 1986-1992 to 0.32/100,000 since 1996. Case reports peaked in the third quarter of each year. Several high-incide...
    File Type:
    Filetype[PDF - 66.14 KB]
  5. Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002–2013
    Personal Author:
    Hatchette, Todd F.; Johnston, B. Lynn; Schleihauf, Emily; Mask, Angela; Haldane, David; Drebot, Michael; Baikie, Maureen; Cole, Teri J.; Fleming, Sarah; Gould, Richard; Lindsay, Robbin;
    Published:
    Oct 2015
    Source:
    Emerg Infect Dis. 21(10):1751-1758.
    Description:
    Ixodes scapularis ticks, which transmit Borrelia burgdorferi, the causative agent of Lyme disease (LD), are endemic to at least 6 regions of Nova Scotia, Canada. To assess the epidemiology and prevalence of LD in Nova Scotia, we analyzed data from 32...
    File Type:
    Filetype[PDF - 532.55 KB]